semaglutide fda lawsuit Novo Nordisk and Hims & Hers settle lawsuit, allowing the telehealth platform to sell FDA-approved Wegovy and Ozempic GLP-1 drugs. Tap link in bio for full story Novo Nordisk sues two pharmacies

Your provider should help you find the dose that works for your body, your goals, and your tolerance

For vision claims: Ophthalmologist records that show any loss of vision, including tests that measure sight and scans for diagnosing conditions like NAION

Phase 2 trial data Tirzepatide Phase 3 trials (SURPASS and SURMOUNT programs) demonstrated weight loss of 15 to 22.5% body weight depending on dose and study population

A research study found that patients expectations were typically greater than what was realistic

People with kidney problems or those who drink excessive alcohol are at higher risk for lactic acidosis